134 related articles for article (PubMed ID: 17346217)
21. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
22. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
[TBL] [Abstract][Full Text] [Related]
23. Multi-faceted roles for CXC-chemokines in prostate cancer progression.
Waugh DJ; Wilson C; Seaton A; Maxwell PJ
Front Biosci; 2008 May; 13():4595-604. PubMed ID: 18508531
[TBL] [Abstract][Full Text] [Related]
24. Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1.
Dambly-Chaudière C; Cubedo N; Ghysen A
BMC Dev Biol; 2007 Mar; 7():23. PubMed ID: 17394634
[TBL] [Abstract][Full Text] [Related]
25. Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain.
Hinton CV; Avraham S; Avraham HK
Clin Exp Metastasis; 2010 Feb; 27(2):97-105. PubMed ID: 18814042
[TBL] [Abstract][Full Text] [Related]
26. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis.
Ratajczak MZ; Zuba-Surma E; Kucia M; Reca R; Wojakowski W; Ratajczak J
Leukemia; 2006 Nov; 20(11):1915-24. PubMed ID: 16900209
[TBL] [Abstract][Full Text] [Related]
27. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
[TBL] [Abstract][Full Text] [Related]
28. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.
Nakayama T; Hieshima K; Izawa D; Tatsumi Y; Kanamaru A; Yoshie O
J Immunol; 2003 Feb; 170(3):1136-40. PubMed ID: 12538668
[TBL] [Abstract][Full Text] [Related]
29. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
[TBL] [Abstract][Full Text] [Related]
30. The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM model.
Menu E; Asosingh K; Indraccolo S; De Raeve H; Van Riet I; Van Valckenborgh E; Vande Broek I; Fujii N; Tamamura H; Van Camp B; Vanderkerken K
Haematologica; 2006 May; 91(5):605-12. PubMed ID: 16627256
[TBL] [Abstract][Full Text] [Related]
31. G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways.
Vlahakis SR; Villasis-Keever A; Gomez T; Vanegas M; Vlahakis N; Paya CV
J Immunol; 2002 Nov; 169(10):5546-54. PubMed ID: 12421931
[TBL] [Abstract][Full Text] [Related]
32. [Major role of stromal cell derived factor and its receptor CXCR4 in the mobilization and homing of hematopoietic stem/progenitor cells - review].
Wang CY; Miao ZC; Feng MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Feb; 12(1):115-9. PubMed ID: 14989785
[TBL] [Abstract][Full Text] [Related]
33. G protein-coupled receptors in haematopoietic disruption.
Ramkissoon SH; Patel HJ; Taborga M; Rameshwar P
Expert Opin Biol Ther; 2006 Feb; 6(2):109-20. PubMed ID: 16436037
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
Martinez-Ordoñez A; Seoane S; Cabezas P; Eiro N; Sendon-Lago J; Macia M; Garcia-Caballero T; Gonzalez LO; Sanchez L; Vizoso F; Perez-Fernandez R
Oncogene; 2018 Mar; 37(11):1430-1444. PubMed ID: 29321662
[TBL] [Abstract][Full Text] [Related]
35. A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II.
Zhou N; Luo Z; Luo J; Hall JW; Huang Z
Biochemistry; 2000 Apr; 39(13):3782-7. PubMed ID: 10736178
[TBL] [Abstract][Full Text] [Related]
36. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
Nazari A; Khorramdelazad H; Hassanshahi G
Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
[TBL] [Abstract][Full Text] [Related]
37. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells.
Fernandis AZ; Prasad A; Band H; Klösel R; Ganju RK
Oncogene; 2004 Jan; 23(1):157-67. PubMed ID: 14712221
[TBL] [Abstract][Full Text] [Related]
38. H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12.
Godot V; Arock M; Garcia G; Capel F; Flys C; Dy M; Emilie D; Humbert M
J Allergy Clin Immunol; 2007 Oct; 120(4):827-34. PubMed ID: 17681365
[TBL] [Abstract][Full Text] [Related]
39. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells.
Van Overstraeten-Schlögel N; Beguin Y; Gothot A
Eur J Haematol; 2006 Jun; 76(6):488-93. PubMed ID: 16494621
[TBL] [Abstract][Full Text] [Related]
40. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
Kijima T; Maulik G; Ma PC; Tibaldi EV; Turner RE; Rollins B; Sattler M; Johnson BE; Salgia R
Cancer Res; 2002 Nov; 62(21):6304-11. PubMed ID: 12414661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
